Source: Markets Insider

Acousia Therapeutics: Hearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11-15

TÜBINGEN, Germany, Nov. 24, 2022 /PRNewswire/ -- Acousia Therapeutics GmbH, and its partners from the Translational Hearing Research Group at the ...

Read full article »

Acousia Therapeutics's Competitors | Acousia Therapeutics's News | Acousia Therapeutics's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

1-25

CEO

Tim Boelke

CEO Approval Rating

90/100

Acousia is a Germany-based clinical-stage biotech company that researches and develops novel therapeutics for the treatment of acute and chronic diseases.